CD274 and cancer: Thus, increased type I IFN activation in DCs in HRD-Dup tumours may serve as an activator of JAK–STAT signalling, with downstream upregulation of human leukocyte antigen (HLA) molecules and PD-L1 in cancer cells and macrophages.